We provide Amazing Industries


Ensuring the highest standards for compliance and quality systems is essential for any pharmaceutical company today. Not only internal operations, but those of business partners or would-be partners, must pass muster. Get pointers on how to vet your suppliers, eliminate weak links in your internal quality systems, and improve staff training.

Experts in this category:

HT Corps have extensive experience in the biological, cosmetic, food, drug, healthcare, medical device and pharmaceutical industries. During the past 10 years, We gained significant experience in auditing, computerized systems validation, drug product, drug substance, expert witness testimony, Drug control compliance, ISO compliance, IT systems implementation, laboratory instrumentation validation, manufacturing equipment validation and project management. We have expert team in Business Management and a professionals with a concentration in information systems

  • The Audit as a Quality Control Mechanism
  • Adequate supervisory control
  • Quality control plans
  • Proper administration of a benefit plan

While the outlook for medical device companies appears positive, unsustainable healthcare costs and new competitive forces threaten to alter the future industry landscape. If today's manufacturers fail to stake their claim in the evolving value chain, they risk being caught in the middle and becoming commoditized.

The days of simply manufacturing a device, and selling it to healthcare providers via distributors, have long vanished. Value is the new byword for success, prevention the preferred clinical outcome and intelligence the new competitive advantage. In this paper, we discuss the pathway to success in 2030 for medical device companies, following a three-pronged strategy:

Reinvent traditional business and operating models by integrating intelligence, delivering services beyond the device, and investing in enabling technology
Reposition for the future competitive landscape, to adapt to challenges presented by new entrants, new technologies and new markets
Reconfigure your position in the value chain of the future, by connecting directly with patients and consumers (B2C), vertically integrating (B2B) and/or transforming into `one-stop-shops' for care